D1 ANTAGONIST IN CLINICAL-TRIAL

被引：21

作者：

CHIPKIN, RE

机构：

来源：

TRENDS IN PHARMACOLOGICAL SCIENCES | 1990年 / 11卷 / 05期

关键词：

D O I：

10.1016/0165-6147(90)90111-K

中图分类号：

R9 [药学];

学科分类号：

1007 ;

摘要：

引用

收藏

页码：185 / 185

页数：1

相关论文

共 4 条

[1] 5-HT3 ANTAGONISTS AND LIGANDS FOR DOPAMINE D1-RECEPTOR AND AUTORECEPTORS OFFER NEW LEADS FOR ANTIPSYCHOTIC-DRUGS [J].

ABBOTT, A .

TRENDS IN PHARMACOLOGICAL SCIENCES, 1990, 11 (02) :49-51

[2] SYNTHESIS AND RECEPTOR AFFINITIES OF SOME CONFORMATIONALLY RESTRICTED ANALOGS OF THE DOPAMINE D1 SELECTIVE LIGAND (5R)-8-CHLORO-2,3,4,5-TETRAHYDRO-3-METHYL-5-PHENYL-1H-3-BENZAZEPIN-7-OL [J].

BERGER, JG ;

CHANG, WK ;

CLADER, JW ;

HOU, D ;

CHIPKIN, RE ;

MCPHAIL, AT .

JOURNAL OF MEDICINAL CHEMISTRY, 1989, 32 (08) :1913-1921

[3]

CHIPKIN RE, 1988, J PHARMACOL EXP THER, V247, P1093

[4]

MCQUADE RD, 1989, FASEB J, V4, pA601